North America Breast Reconstruction Market Size, Share & Trends Analysis Report By Product (Implants, Tissue Expander), By Shape (Round, Anatomical), By End-use (Hospitals, Cosmetology Clinics) By Region And Segment Forecasts, 2022 - 2030

Report Overview

The North America breast reconstruction market size was valued at USD 206.10 million in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 6.69% from 2022 to 2030. Rising breast cancer patients and an increase in the number of breast reconstruction surgeries are the major factors driving the market. Moreover, the availability of reimbursement policies with respect to breast reconstruction is further boosting the North America breast reconstruction market.

The incidence rate of breast cancer has increased considerably in the past two decades. For instance, as per Cancer.net, from the mid-2000s, invasive breast cancer in women has increased approximately by half a percent every year. Moreover, as per a similar source, it is estimated that 287,850 women in the U.S. are expected to be diagnosed with invasive breast cancer in 2022.

Additionally, as per the Canadian Cancer Society, breast cancer is the most common cancer among Canadian women. For instance, according to a similar source, it is estimated that 27,700 Canadian women were expected to be diagnosed with breast cancer. Moreover, 13.0% of the women were expected to die from breast cancer. To minimize the risk of breast cancer, many women opt for mastectomy & lumpectomy procedures; as a result, the demand for breast reconstruction products is anticipated to increase throughout the forecast period.

The growing adoption of breast reconstruction procedures is another factor responsible to drive the North America breast reconstruction market. For instance, American Society of Plastic Surgeons, the overall breast reconstruction procedures were calculated to be 137,808in 2020, which is 75.0% more than the breast reconstruction surgeries, held in 2000. Thus, the growing demand for breast reconstruction procedures may boost the North America breast reconstruction market, during the forecast period.

Furthermore, Medicare usually does not cover most cosmetic surgeries. However, Medicare covers breast reconstruction only if the person has had a mastectomy due to breast cancer. According to Mentor Medical Systems B.V., the Medicare national average payment may vary from USD 147 to USD 10,623 depending upon the procedure.

Moreover, the national average payment also varies depending upon the place where the surgery takes place. For instance, the breast reconstruction by a physician is reimbursed at an average payment of USD 1,193, whereas, the similar is reimbursed at a payment of USD 14,929 and USD 5,635 at hospital outpatient and ambulatory surgical centers respectively. Therefore, the availability of suitable reimbursement policies is promoting breast reconstruction in women who had a mastectomy, which is expected to help the development of the North America breast reconstruction market during the forecast period.

The COVID-19 pandemic was anticipated to have a negative impact on the North America breast reconstruction market. This can be attributed to the termination & delay of elective treatments including breast reconstruction. However, as the cases of COVID-19 have reduced, and vaccination has started globally, elective surgery for breast reconstruction is expected to take place. This may push the market growth during the forecast period. Moreover, to cope with the demand, and have a larger patient reach, many companies adopted strategies such as raising awareness campaigns, partnerships, and product approvals.

Besides, some companies opted for clinical trials during the post-pandemic period, which was expected to boost the North America breast reconstruction market growth. For instance, in March 2021, Surgical Innovation Associates initiated a clinical trial under an Investigational Device Exemption from the U.S. FDA, which accessed the durability & effectiveness of their product Dura Sorb. This was expected to drive the company’s market growth.

Similarly, in October 2021, Sientra, Inc. and Mission Plasticos launched a nationwide Reshaping Lives: Full Circle program, to provide reconstructive breast surgery for women living in poverty. Thus, with such strategies initiated by the key players, the North America breast reconstruction market is projected to witness significant growth during the post-pandemic period.

Product Insights

Based on the product, implants held the largest market share of 63.40% in 2021. This can be attributed to the availability of various breast implants such as silicone breast implants & saline breast implants. Moreover, the FDA has approved the use of such breast implants in women aged 22 and above. Additionally, the FDA overturned the ban on silicone implants, while also approving silicone gel implants manufactured by 2 leading companies Mentor LLC & Allergen in the same year.

Moreover, as per data collected by NCBI, around 8.08 women per 1000 in the U.S. reported having some type of breast implant. Furthermore, breast implants provide various advantages such as shorter hospital stays, less complex surgery, and quick recovery time. Thus, due to the above-mentioned factors; women tend to opt for breast implants, thereby boosting the North America breast reconstruction market.

However, the tissue expander is projected to witness the fastest growth rate of 6.85% during the forecast period. The tissue expander is extensively used in breast reconstruction surgeries. For instance, the two-stage expander to implant breast reconstruction accounts for more than 67.0% of all breast reconstruction surgeries in the U.S. Moreover, according to a study at NCBI in 2019, the 2-stage tissue expander, to the implant procedure, was the most common & considerably evolved technique since the 1980s.

Additionally, the presence of some major players such as Allergan PLC, Johnson & Johnson Services Inc., and Air X pander Inc. is further expected to boost the segment growth. Thus, due to the aforementioned factors, the tissue expander is projected to witness a significant growth rate, during the forecast period.

Shape Insights

Based on the shape, the round shape is expected to have the largest market share of 55.30% during the forecast period. This can be credited to the advantages a round implant provides. For instance, around breast implant provides women with a fuller look & appearance. Moreover, these are symmetrical in appearance from all angles and are more affordable than teardrop-shaped implants.

However, the anatomical shape is expected to witness the fastest CAGR of 6.81% during the forecast period. This can be credited to various advantages an anatomical shape breast implant provides. For instance, anatomical-shaped implants mimic the curves of the natural breast for subtle enhancement. Moreover, it provides a textured surface for better grip, which helps keep the implant in place. Furthermore, the rough surface helps in minimizing hardened scar tissue capsules, all over the implant.

Additionally, they provide better results, as their texture makes them ideal for breast augmentation in females with little breast tissue. Thus, due to the above-mentioned factors, the segment is expected to have a lucrative growth over the forecast period.

End-use Insights

Based on the end-use, the hospitals segment is expected to dominate with a market share of 55.28% in 2021. This can be credited to the increasing number of hospitals in the North America region. For instance, according to a study published by American Hospital Association in the 2022 edition, the number of hospitals in the U.S. was estimated to be 6,093 in 2020. Similarly, as per The Canadian Encyclopedia, there are 706 public & 193 private hospitals in Canada. Therefore, the rise in a number of hospitals provides patients with several options for breast reconstruction surgeries, thereby impelling the North America breast reconstruction market growth.

However, the cosmetology clinics segment is projected to witness the fastest growth rate of 6.91% during the forecast period. This can be credited to the rise in the number of cosmetologists in this region. For instance, according to Zippia, as of 2021, there were more than 196,744 licensed cosmetologists in the U.S. Increase in the number of cosmetologists is expected to augment the number of cosmetology clinics in this region, thereby boosting the segment growth. 

Regional Insights

The U.S. is anticipated to have the largest market share of 74.51% in 2021. This can be credited to the number of breast cancer patients in the U.S. For instance, as per Breastcancer.org, 1 in every 8 women in the U.S. will develop invasive breast cancer in their lifetime. Moreover, according to a similar source, 30.0% of the newly diagnosed cancer in American women is estimated to be breast cancer. Thus, rising cases of breast cancer are expected to increase the mastectomy procedure, which in turn may boost the North America breast reconstruction market.

Additionally, there has been a rise in breast reconstructive procedures conducted in the U.S. For instance, as per NCBI, breast reconstruction surgery in the U.S. increased by 29.0% from 2000 to 2018. Similarly, there have been increasing cases of breast reconstruction post-mastectomy.  For instance, according to a study at the National Library of Medicine, 40.0% of women in the U.S. have breast reconstruction surgery post-mastectomy.  Thus, due to the aforementioned factors, the U.S. is expected to dominate the North America breast reconstruction market.

However, Canada is projected to witness the fastest growth rate over the forecast period. This can be credited to the robust healthcare system in Canada, along with rising cases of breast cancer. For instance, as per the estimates of the Canadian Cancer Society, in 2021, approximately 27,700 women will be diagnosed with breast cancer, representing around 25.0% of all new cancer cases in women. Furthermore, approximately 76 women are diagnosed with breast cancer every day in Canada. Thus, mastectomy procedures in Canada are expected to increase, which is further anticipated to impel the North America breast construction market.

Key Companies & Market Share Insights

The North America breast reconstruction market is fragmented in nature and has many players in the market. The degree of competition and competitive rivalry among the key players is expected to intensify during this period. Moreover, many market players are opting for several strategies such as product approval, partnership, and mergers to have a competitive edge over its competitor.

For instance, in December 2020, Motiva USA LLC received a CE mark for its next-generation Motive Ergonomicx2 silicone breast implant platform. Additionally, the company also received a CE mark for the Motiva Ergonomix2 Diamond breast implant which is intended to be used with the Motiva MIA system. Similarly, in July 2021, BD acquired Tepha, Inc. This helped BD to use Tepha’s patented resorbable polymer to expand their mesh portfolio’s innovation potential for soft tissue repair, reconstruction & regeneration segments. Thus, with the above-mentioned strategies, the North America breast reconstruction market is likely to propel during the forecast period. Some of the key players in the North America breast reconstruction market include:

• Mentor Medical Systems B.V. (Johnson & Johnson)

• Abbvie (Allergan Inc.)

• Integra Life sciences Corporation

• Sientra, Inc.

• Ideal Implant Incorporated

• Stryker Corporation

• Establishment Labs Holding, Inc. (Motiva USA LLC)

• RTI Surgical

• MTF Biologics

• SIA (Surgical Innovation Associates)

• Tela Bio, Inc.

North America Breast Reconstruction Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at regional and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the North America Breast Reconstruction Market Report based on the product, shape, end-use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Implants

    • Silicone Breast Implants

    • Saline Breast Implants

  • Tissue Expander

    • Saline Expander

    • Air Tissue Expander

  • Acellular Dermal Matrix

• Shape Outlook (Revenue, USD Million, 2018 - 2030)

  • Round Shape

  • Anatomical Shape

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Cosmetology Clinics

  • Ambulatory Surgical Centers

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada